Van Der Sligte NE, Krumbholz M, Pastorczak A, Scheijen B, Tauer JT, Nowasz C, Sonneveld E, De Bock GH, Meeuwsen-De Boer TGJ, Van Reijmersdal S, Kuiper RP, Bradtke J, Metzler M, Suttorp M, De Bont ESJM, Van Leeuwen FN (2014)
Publication Type: Journal article
Publication year: 2014
Publisher: Wiley-Blackwell
Book Volume: 166
Pages Range: 250-3
Journal Issue: 2
DOI: 10.1111/bjh.12850
Early recognition of children with chronic phase chronic myeloid leukaemia (CML-CP) at risk for developing a lymphoid blast crisis (LyBC) is desirable, because therapy options in CML-LyBC are limited. We used Multiplex Ligation-dependent Probe Amplification to determine whether B-cell lymphoid leukaemia-specific copy number alterations (CNAs) (e.g. IKZF1, PAX5, CDKN2A deletions) could be detected in CML-CP and may be used to predict disease progression to LyBC. CNAs were detected in all patients with CML-LyBC, but in none of the 77 patients with CML-CP. Based on this study we conclude that CNAs remain a hallmark of disease progression.
APA:
Van Der Sligte, N.E., Krumbholz, M., Pastorczak, A., Scheijen, B., Tauer, J.T., Nowasz, C.,... Van Leeuwen, F.N. (2014). DNA copy number alterations mark disease progression in paediatric chronic myeloid leukaemia. British Journal of Haematology, 166(2), 250-3. https://doi.org/10.1111/bjh.12850
MLA:
Van Der Sligte, Naomi E., et al. "DNA copy number alterations mark disease progression in paediatric chronic myeloid leukaemia." British Journal of Haematology 166.2 (2014): 250-3.
BibTeX: Download